Armistice Capital, LLC Sol Gel Technologies Ltd. Transaction History

Armistice Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.66 - $1.05 $30,360 - $48,300	-46,000 Reduced 2.21%	2,032,000 $1.81 Million
Q1 2024 May 15, 2024	SELL	$0.95 - $1.5 $54,150 - $85,500	-57,000 Reduced 2.67%	2,078,000 $2.04 Million
Q3 2023 Nov 14, 2023	SELL	$1.63 - $3.94 $118,989 - $287,620	-73,000 Reduced 3.31%	2,135,000 $3.48 Million
Q2 2023 Aug 14, 2023	SELL	$2.99 - $4.15 $598,000 - $830,000	-200,000 Reduced 8.31%	2,208,000 $6.6 Million
Q1 2023 May 15, 2023	BUY	$3.44 - $5.32 $8.28 Million - $12.8 Million	2,408,000 New	2,408,000 $9.34 Million

5.35M

1.5K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $12.5M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.